Recent advances in basic and clinical aspects of inflammatory bowel disease: Which steps in the mucosal inflammation should we block for the treatment of inflammatory bowel disease?

doi:10.3748/wjg.v13.i15.2145

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 13, Issue 15

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3332)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-2) series.

Item

Count

PDF

278

HTML

2845

Figures (1-2)

209

Sum=3332

Apr 21, 2007 (publication date) through May 15, 2024

Times Cited of This Article

Times Cited (14)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Editorial

World J Gastroenterol. Apr 21, 2007; 13(15): 2145-2149
Published online Apr 21, 2007. doi: 10.3748/wjg.v13.i15.2145

Full Size Figure Download Figure

Figure 1 Schema of the pathogenesis of Crohn’s disease. TLR: toll-like receptors; IL: interleukin; TNF: tumor necrosis factor; ECM: extracellular matrix; TGF: transforming growth factor.

Citation: Asakura H, Suzuki K, Honma T. Recent advances in basic and clinical aspects of inflammatory bowel disease: Which steps in the mucosal inflammation should we block for the treatment of inflammatory bowel disease? World J Gastroenterol 2007; 13(15): 2145-2149
URL: https://www.wjgnet.com/1007-9327/full/v13/i15/2145.htm
DOI: https://dx.doi.org/10.3748/wjg.v13.i15.2145